GLP-1 drugs are fueling the rise of the 'big kids' market, one mega restaurant chain says
· businessinsider.com
Diners on GLP-1 drugs are increasingly opting for smaller kids meals, said Cava CEO Brett Schulman.
Kids' meals are in vogue, according to Cava CEO Brett Schulman.
The slop bowl chain is seeing an increasing consumer base that he calls "big kids" — adult cu...